Stockreport

How Investors May Respond To Bicara Therapeutics (BCAX) FDA Breakthrough Therapy Nod for Lead Immunotherapy [Yahoo! Finance]

Bicara Therapeutics Inc.  (BCAX) 
PDF immunotherapy combination, ficerafusp alfa with pembrolizumab, for the first-line treatment of metastatic or unresectable, recurrent HPV-negative head and neck squamous [Read more]